http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002530420-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-08 |
| filingDate | 1999-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002530420-A |
| titleOfInvention | Benzylmaltotrioside as an inhibitor of smooth muscle cell proliferation |
| abstract | (57) Abstract: The present invention provides a compound represented by the formula (I) having the following structure, wherein X is (A); wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently hydrogen, acyl having 2 to 7 carbons, perfluoroacyl having 2 to 10 carbons, alkyl having 1 to 6 carbons, alkyl having 1 to 6 carbons M is hydrogen, lithium, sodium, potassium or ammonium; R 11 is hydrogen, alkyl having 1 to 6 carbons, perfluoroalkyl having 1 to 6 carbons, halogen, perfluoroalkyl, benzoyl, benzyl or —SO 3 M; nitrile, alkoxy nitro or 1 to 6 carbon atoms; R 1 2 is hydrogen, nitro, amino, acylamino having 2 to 7 carbon atoms, a perfluoroalkyl acyl amino having 2 to 7 carbon atoms, alkylamino of 1 to 6 carbon atoms, Having 1 to 6 carbon atoms Fluoroalkylamino, dialkylamino (where each alkyl chain independently has 1 to 6 carbon atoms), perfluorodialkylamino (where each alkyl chain independently has 1 to 6 carbon atoms), Alkylsulfonylamino having 1 to 6 carbon atoms, perfluoroalkylsulfonylamino having 1 to 6 carbon atoms, arylsulfonylamino having 6 to 10 carbon atoms or halo-substituted arylsulfonylamino having 6 to 10 carbon atoms] An inhibitor or a pharmaceutically acceptable salt thereof is provided. Embedded image |
| priorityDate | 1998-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.